Chemical Identity and Structural Features

6-Bromo-2,4-dichloropyrido[2,3-d]pyrimidine (SKU B172823) is a fused bicyclic heteroaromatic compound consisting of a pyrimidine ring annulated with a pyridine ring in the [2,3-d] orientation. The molecule bears three leaving-group-capable halogen substituents: two chlorine atoms at the 2- and 4-positions of the pyrimidine ring and one bromine atom at the 6-position of the pyridine ring.

This strategic pattern of halogenation endows the scaffold with pronounced electrophilic character at multiple sites, enabling sequential, chemoselective functionalization. The 4-chloro position is typically the most electrophilic and reactive toward nucleophilic aromatic substitution (SNAr), followed by the 2-chloro position, while the 6-bromo substituent is ideally suited for transition-metal-catalyzed cross-coupling reactions such as Suzuki–Miyaura, Buchwald–Hartwig, and Negishi couplings. This orthogonal reactivity profile makes the compound an exceptionally versatile synthon in multi-step synthetic routes.

Recommended Storage and Handling Procedures

Storage: Store 6-bromo-2,4-dichloropyrido[2,3-d]pyrimidine in a tightly sealed container in a cool, dry, and well-ventilated location, away from moisture, direct light, and incompatible materials such as strong bases, strong oxidizers, and reactive nucleophiles. Desiccant packs are recommended when storing opened containers. Confirm exact recommended temperature range and long-term stability data from the product certificate of analysis (CoA).

Personal Protective Equipment (PPE): Researchers should wear appropriate PPE including nitrile gloves, safety goggles, and a laboratory coat when handling this compound. Operations that may generate dust or aerosols should be conducted inside a chemical fume hood.

Weighing and Dissolution: Weigh quantities in a fume hood to minimize inhalation exposure. The compound is soluble in common organic solvents including dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dichloromethane (DCM), and tetrahydrofuran (THF). Avoid prolonged exposure to protic solvents or aqueous systems without a co-solvent, as hydrolysis of the chloro substituents may occur under some conditions.

Waste Disposal: Dispose of all waste materials in accordance with institutional, local, and national regulations for halogenated organic waste. Do not pour solutions containing this compound down the drain.

Applications in Medicinal Chemistry and Drug Discovery

The pyrido[2,3-d]pyrimidine core is a privileged scaffold in drug discovery, particularly for the design and synthesis of small-molecule kinase inhibitors. The fused bicyclic nitrogen-rich framework mimics purine and can bind effectively within ATP-binding pockets of protein kinases. 6-Bromo-2,4-dichloropyrido[2,3-d]pyrimidine serves as a key starting material or advanced intermediate for constructing such inhibitors.

Sequential Functionalization Strategy: A typical synthetic approach exploits the differential reactivity of the three halogen substituents. First, selective SNAr at the 4-position with an amine nucleophile (e.g., an aniline or aliphatic amine) installs an amino group that can serve as a hinge-binding motif in kinase active sites. Second, further SNAr or nucleophilic substitution at the 2-position introduces a second amine or other nucleophile for selectivity optimization. Third, the 6-bromo group is engaged in palladium-catalyzed cross-coupling to introduce aryl, heteroaryl, vinyl, or alkyl fragments that project into hydrophobic regions of the binding site.

Relevant Therapeutic Areas: Compounds derived from this scaffold have been investigated in the context of oncology (targeting receptor tyrosine kinases and non-receptor kinases), inflammatory disease, and antiviral research. Specific biological activity data for derivatives should be verified against peer-reviewed primary literature.

Quality, Purity, and Regulatory Considerations

Purity Verification: Aladdin Scientific supplies 6-bromo-2,4-dichloropyrido[2,3-d]pyrimidine (SKU B172823) with a certificate of analysis (CoA) that documents purity as determined by analytical methods such as HPLC and/or NMR. Researchers should review the CoA for each lot prior to use, particularly for sensitive biological assays where impurities may confound results.

Structural Confirmation: Confirm compound identity using ¹H NMR, ¹³C NMR, and mass spectrometry before use in critical experiments. Characteristic NMR signals will reflect the aromatic protons of the pyrido[2,3-d]pyrimidine scaffold and the absence of signals corresponding to residual starting materials.

Regulatory Status: This compound is intended for research use only and is not approved for use in humans, animals, or food products. Researchers are responsible for compliance with all applicable institutional biosafety, chemical safety, and import/export regulations governing halogenated heterocyclic research chemicals.

Lot-to-Lot Consistency: When reproducibility across experiments is essential, researchers should request lot-specific CoA documentation and, where possible, reserve sufficient material from a single lot for a complete study series.